@waynesworld, care to shed any light on where this trial fits into the Gene Therapy picture as it appeared in the latest MD news - seems they are excited about the news?
Dosing Begins in Phase 3 Trial of Pfizer's Gene Therapy for Duchenne (musculardystrophynews.com)
Thanking you in anticipation of your reply
Cheers
.
Sarepta gene therapy study missed key target in Duchennes, page-117
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.6¢ |
Change
0.001(1.18%) |
Mkt cap ! $77.53M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.8¢ | 8.4¢ | $18.63K | 218.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 8.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.6¢ | 46681 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable